Ductal growth is impeded in mammary glands of C-neu transgenic mice

The steroid hormone, estradiol, is essential for both the growth of normal breast and induction of mammary carcinomas. The growth promoting effects of estrogen are presumed to be mediated by growth factors, in particular, epidermal growth factor, which mediates its effects through erbB receptors, erbB1 and erbB2/C-neu. C-neu is amplified and over-expressed in a large number of human cancers and transgenic mice over-expressing C-neu also develop mammary tumors. However, as yet, the impact of C-neu over-expression on estrogen action during normal mammary development and hence, its precise role in carcinogenesis, remains unclear. In the present studies, we demonstrate that estradiol-dependent mammary ductal growth accompanying puberty is impaired in transgenic mice expressing wild type C-neu, and is intrinsic to the tissue. The impairment is not due to an overall impairment in estrogen action, since progesterone receptor expression is unaffected in C-neu mice. It is also not due to an intrinsic inability of the epithelial cells to proliferate, since impeded ductal growth co-exists with alveolar growth during pregnancy. Therefore, we propose that, depending on the physiological state, C-neu may either promote or inhibit the growth of mammary epithelial cells, and discuss its potential significance to carcinogenesis.

[1]  M. Neville,et al.  The Mammary gland : development, regulation, and function , 1987 .

[2]  B. O’Malley,et al.  Molecular mechanisms of action of steroid/thyroid receptor superfamily members. , 1994, Annual review of biochemistry.

[3]  W Godolphin,et al.  Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer. , 1989, Science.

[4]  G. Shyamala,et al.  Progesterone receptors in the mouse mammary duct: distribution and developmental regulation. , 1996, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[5]  S. Haslam Progesterone effects on deoxyribonucleic acid synthesis in normal mouse mammary glands. , 1988, Endocrinology.

[6]  M. Barcellos-Hoff,et al.  Transgenic mice carrying an imbalance in the native ratio of A to B forms of progesterone receptor exhibit developmental abnormalities in mammary glands. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[7]  S. Haslam,et al.  Estrogen and progesterone receptors in normal mammary gland during different functional states. , 1980 .

[8]  D P McDonnell,et al.  Human progesterone receptor A form is a cell- and promoter-specific repressor of human progesterone receptor B function. , 1993, Molecular endocrinology.

[9]  G. Shyamala Endocrine and other Influences in the Normal Development of the Breast , 1987 .

[10]  F. Bresciani TOPOGRAPHY OF DNA SYNTHESIS IN THE MAMMARY GLAND OF THE C3H MOUSE AND ITS CONTROL BY OVARIAN HORMONES: AN AUTORADIOGRAPHIC STUDY , 1968 .

[11]  S. Coleman,et al.  Inhibition of mouse mammary ductal morphogenesis and down-regulation of the EGF receptor by epidermal growth factor. , 1990, Developmental biology.

[12]  W. McGuire,et al.  Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene. , 1987, Science.

[13]  W. Muller,et al.  Mammary tumors expressing the neu proto-oncogene possess elevated c-Src tyrosine kinase activity , 1994, Molecular and cellular biology.

[14]  R. Cardiff,et al.  Activated neu Induces Rapid Tumor Progression (*) , 1996, The Journal of Biological Chemistry.

[15]  M. Hung,et al.  Transcriptional repression of the neu protooncogene by estrogen stimulated estrogen receptor. , 1992, Cancer research.

[16]  M. De Bortoli,et al.  Tamoxifen up-regulates c-erbB-2 expression in oestrogen-responsive breast cancer cells in vitro. , 1992, European journal of cancer.

[17]  R. Cardiff,et al.  Synergistic interaction of the Neu proto-oncogene product and transforming growth factor alpha in the mammary epithelium of transgenic mice , 1996, Molecular and cellular biology.

[18]  R. Cardiff,et al.  Elevated expression of activated forms of Neu/ErbB‐2 and ErbB‐3 are involved in the induction of mammary tumors in transgenic mice: implications for human breast cancer , 1999, The EMBO journal.

[19]  G. Shyamala,et al.  Essential role of endogenous estrogen in directly stimulating mammary growth demonstrated by implants containing pure antiestrogens. , 1994, Endocrinology.

[20]  R. Cardiff,et al.  Expression of the neu protooncogene in the mammary epithelium of transgenic mice induces metastatic disease. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[21]  N. Hynes,et al.  ErbB‐2, the preferred heterodimerization partner of all ErbB receptors, is a mediator of lateral signaling , 1997, The EMBO journal.

[22]  K. Umesono,et al.  The nuclear receptor superfamily: The second decade , 1995, Cell.

[23]  P. Webb,et al.  Characterization of response elements for androgens, glucocorticoids and progestins in mouse mammary tumour virus. , 1988, Nucleic acids research.

[24]  R. Cardiff,et al.  Impact of progesterone receptor on cell-fate decisions during mammary gland development. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[25]  G. Shyamala,et al.  Developmental regulation of murine mammary progesterone receptor gene expression. , 1990, Endocrinology.

[26]  S. Snedeker,et al.  Expression and functional properties of transforming growth factor alpha and epidermal growth factor during mouse mammary gland ductal morphogenesis. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[27]  S. Haslam,et al.  Printed in U.S.A. Copyright © 1999 by The Endocrine Society A Mouse Model to Study the Effects of Hormone Replacement Therapy on Normal Mammary Gland during Menopause: Enhanced Proliferative Response to Estrogen in Late Postmenopausal Mice* , 2022 .

[28]  M. Barcellos-Hoff,et al.  In situ localization of progesterone receptors in normal mouse mammary glands: Absence of receptors in the connective and adipose stroma and a heterogeneous distribution in the epithelium , 1997, The Journal of Steroid Biochemistry and Molecular Biology.

[29]  B. O’Malley,et al.  Mice lacking progesterone receptor exhibit pleiotropic reproductive abnormalities. , 1995, Genes & development.

[30]  B. Katzenellenbogen,et al.  Hormonal modulation of HER-2/neu protooncogene messenger ribonucleic acid and p185 protein expression in human breast cancer cell lines. , 1990, Cancer research.

[31]  R. Cardiff,et al.  Differential expression of the neu transgene in murine mammary tissues. , 1997, International journal of oncology.

[32]  S. Coleman,et al.  Ductal morphogenesis in the mouse mammary gland: evidence supporting a role for epidermal growth factor. , 1988, Developmental biology.

[33]  G. G. Stokes "J." , 1890, The New Yale Book of Quotations.